Home Newsfeeds Google Says Starting Today, Rolling Out Over Next Few Weeks, Expanding VPN Access To All Google One Plans, Including Basic Plan That Starts At $1.99/Month

News

Google Says Starting Today, Rolling Out Over Next Few Weeks, Expanding VPN Access To All Google One Plans, Including Basic Plan That Starts At $1.99/Month

– Reuters

byHappy Mohamed

March 8, 2023

1 minute read

– Reuters

Southern Company Needs To Examine Its Portfolio: Why This Analyst Is Bullish

By Priya Nigam

October 20, 12:15 PM

The completion of the Vogtle 3 nuclear load is a “major milestone” for Southern Co (NYSE: SO) and indicates that the commencement of the Unit is now imminent, according to KeyBanc Capital Markets.

Movers
News

What’s Going On With Robinhood Stock?

By Erica Kollmann

June 7, 3:33 PM

Robinhood Markets shares are trading lower Friday and the stock is up more than 30% over the past month. Here's a look at what's going on.

HOOD

Nvidia’s New H200 GPU Promises to Outpace Competition in AI Hardware Race

By Anusuya Lahiri

November 13, 1:15 PM

Nvidia Corp (NASDAQ: NVDA) showcased its H200 graphics processing unit, an upgrade from the H100, the chip OpenAI used to train GPT-4. Nvidia expects around $16 billion of revenue for its Q3, up 170% year-on-year.

AMD

Legal
News

BeiGene To Vigorously Defend Patent Infringement Allegations By Pharmacyclics

By Benzinga Newsdesk

June 15, 8:39 AM

BeiGene (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)))), a global biotechnology company, is aware that Pharmacyclics LLC has filed a complaint against BeiGene, Ltd. and BeiGene USA, Inc., alleging that BeiGene's

ABBV

Google Says Starting Today, Rolling Out Over Next Few Weeks, Expanding VPN Access To All Google One Plans, Including Basic Plan That Starts At $1.99/Month

Related Posts

Southern Company Needs To Examine Its Portfolio: Why This Analyst Is Bullish

What’s Going On With Robinhood Stock?

Nvidia’s New H200 GPU Promises to Outpace Competition in AI Hardware Race

BeiGene To Vigorously Defend Patent Infringement Allegations By Pharmacyclics